Related Experiment Video
Updated: May 13, 2026

07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Multiple primary malignancies in elderly patients with high-grade soft tissue sarcoma
Eiji Kozawa1, Hideshi Sugiura, Satoshi Tsukushi
1Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.
International Journal of Clinical Oncology
|March 21, 2013
Summary
Elderly patients with high-grade soft tissue sarcomas (STS) and multiple malignancies showed a better prognosis than those with a single STS. Awareness of secondary cancers and careful treatment planning are crucial for these patients.
Area of Science:
- Oncology
- Geriatric Medicine
- Surgical Pathology
Background:
- Limited research exists on multiple primary malignancies involving soft tissue sarcomas (STS), unlike more common epithelial tumors.
- Existing studies primarily focus on epithelial cancers, leaving a gap in understanding STS comorbidities.
Purpose of the Study:
- To analyze clinical features and challenges in elderly patients (≥65 years) with high-grade STS and multiple malignancies.
- To compare outcomes of elderly patients with high-grade STS and multiple malignancies versus those with a single STS diagnosis.
Main Methods:
- Retrospective analysis of 107 elderly patients (≥65 years) diagnosed with high-grade STS.
- Comparison of clinical features and survival rates between patients with STS only (S group) and those with multiple primary malignancies (M group).
Main Results:
- 21% of patients had multiple primary malignancies; 30% of these had diagnoses within one year.
- Treatment for concurrent malignancies impacted modality selection in 5 of 7 patients.
- Five-year overall survival was higher in the multiple malignancy group (79%) compared to the single STS group (69%), though not statistically significant (P=0.095).
Conclusions:
- Multiple malignancies in elderly patients with STS are not associated with a poorer prognosis and may indicate a better outcome.
- Clinicians must consider the potential for secondary malignancies in STS patients.
- Careful organization and selection of treatment modalities are essential for managing patients with multiple co-occurring cancers.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

